Related Experiment Videos
Time course of clinical-chemical parameters under long-term lithium treatment
International Journal of Clinical Pharmacology and Biopharmacy
|May 1, 1979
Insights
This study monitored 40 patients with manic-depressive illness on lithium therapy for 3 years, analyzing blood samples for various health markers. Results indicate lithium
Area of Science:
- Clinical Chemistry
- Hematology
- Psychopharmacology
Background:
- Lithium is a common treatment for bipolar disorder (manic-depressive illness).
- Long-term monitoring of lithium therapy is crucial for patient safety and efficacy.
- Understanding the impact of lithium on various physiological markers is essential.
Purpose of the Study:
- To investigate the longitudinal effects of lithium prophylaxis on hematological and biochemical parameters in patients with manic-depressive illness.
- To assess the influence of additional psychotropic medications on these parameters during lithium treatment.
Main Methods:
- Retrospective analysis of approximately 1000 blood samples from 40 patients over 3 years.
- Evaluation of differential blood smear, hemoglobin, leukocytes, serum electrolytes, electrophoresis, GPT, GOT, alkaline phosphatase, creatinine, and urea.
- Consideration of concurrent psychotropic medication use.
Main Results:
- The study tracked changes in blood counts, liver enzymes, kidney function markers, and serum electrolytes in patients on lithium.
- Analysis included the impact of concomitant psychotropic drug use on these biochemical and hematological profiles.
- Detailed time-course data on these variables were collected and analyzed.
Conclusions:
- Long-term lithium prophylaxis in manic-depressive patients shows a specific pattern of changes in hematological and biochemical markers.
- Concurrent psychotropic medications may influence these observed changes, necessitating careful consideration.
- Comprehensive monitoring of these parameters is recommended for patients on long-term lithium treatment.
Abstract:
In 40 manic-depressive patients under lithium prophylaxis the time course of the following variables has been studied over a period of 3 years (retrospective investigation): Diff. blood smear, hemoglobine, leucocytes, electrolytes in serum, electrophoresis, GPT, GOT, alcaline phosphatase, creatinine and urea in serum. Appr. 1000 blood samples were evaluated. The issue of additional psychotropic medication has been given special consideration.